Availability of Complement Bound toStaphylococcus aureusTo Interact with Membrane Complement Receptors Influences Efficiency of Phagocytosis
Authors:
Open Access
- 1 February 2003
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (2) , 682-689
Abstract
Complement-mediated opsonization of encapsulatedStaphylococcus aureus(CP+) of the predominant capsule types, 5 and 8, remains poorly understood. Our previous work showed that complement is important for mouse survival of CP+ type 5 bacteremia and that the type 5 capsule inhibits the binding of opsonic C3 fragments to the organism. The importance of complement-mediated opsonization of CP+ was tested by neutrophil phagocytosis assays. Complement-mediated opsonization of CP+ increased phagocytosis by 57% compared to opsonization in complement-inhibited serum. Agar-grown CP+, enhancing capsule expression, was phagocytosed only one-tenth as well as the capsule-negative organisms (CP−), supporting the belief that staphylococcal polysaccharide capsules impair phagocytosis. Despite relatively poor phagocytosis of CP+ compared to CP−, complement activation increased the phagocytosis of CP+ by 103%. Thus, complement in normal human serum may have an important role in opsonizing CP+, even when capsule expression is strong. The ability of bound C3 fragments to interact with complement receptor 1 (CD35) on the membrane of human erythrocytes was tested in an immune adherence assay.S. aureuscapsule was able to mask C3 fragments on the organism from binding to complement receptor 1. The inhibition of C3 binding to CP+ and the masking of deposited C3 fragments caused by the presence of capsule was associated with markedly decreased phagocytosis. The addition of anti-capsule antibodies to normal human serum was found to markedly improve the recognition of deposited C3 fragments by complement receptor 1 even when the absolute number of C3 molecules bound toS. aureuswas not increased.Keywords
This publication has 25 references indexed in Scilit:
- Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 2002
- Capsule Production and Growth Phase Influence Binding of Complement toStaphylococcus aureusInfection and Immunity, 2001
- Staphylococcus aureus Cap5O Has UDP-ManNAc Dehydrogenase Activity and Is Essential for Capsule ExpressionInfection and Immunity, 2001
- Methicillin-ResistantStaphylococcus aureusin the Community: A Hospital-Based StudyInfection Control & Hospital Epidemiology, 1999
- Emergence of Vancomycin Resistance inStaphylococcus aureusNew England Journal of Medicine, 1999
- The Economic Impact of Staphylococcus aureus Infection in New York City HospitalsEmerging Infectious Diseases, 1999
- Staphylococcus aureus Microcapsule Expression Attenuates Bacterial Virulence in a Rat Model of Experimental EndocarditisThe Journal of Infectious Diseases, 1992
- C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.Journal of Experimental Medicine, 1984
- A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.Journal of Clinical Investigation, 1982
- Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.Journal of Clinical Investigation, 1980